This study investigates the use of high molecular weight polyethylene oxide (PEO WSR coagulant) for the preparation of sustained release matrix tablets containing high dose, highly water soluble drug, tramadol HCl. Proportion of PEO polymer, type of insoluble filler, proportion of tramadol HCl, amount of drug in tablet, tablet diameter and compression pressure were recognized as critical formulation and process parameters and their influence on drug release and tablet mechanical properties was evaluated. Percentages of tramadol HCl released after 30 and 240 min were selected for evaluation of drug release, while tensile strength was used as indicator of tablet mechanical properties. Only proportion of tramadol HCl exhibits statistically significant effect on percentages of tramadol HCl released after 30 and 240 min, with higher, wherein increasing of the tramadol HCl proportion increased its release rate among the evaluated variables in selected ranges. All of the investigated factors exhibit statistically significant effect on tablets tensile strength, with the largest influence of filler type. Tablets prepared with highly compressible filler (microcrystalline cellulose) exhibit higher tensile strength and therefore better mechanical properties to those prepared with partially pregelatinized starch (starch 1500).
molecular weight PEOs have been successfully used in the preparation of sustained release matrix tablets by direct compression, containing either water soluble or insoluble drug [6, 7] . Once in contact with water, the PEO matrix starts to swell due to formation of hydrogen bonds between polymeric chains and water. Formation of the hydrophilic gel layer is responsible for prolonged drug release [8] . Basic processes, which determine drug release from hydrophilic matrix tablets, are drug diffusion through the gel layer as well as erosion of the swollen gel layer [9] . Solubility of the drug has profound influence on the mechanism that determined drug release from matrix and should be considered in selecting proper type and grade of matrix polymer. Release of highly water soluble drug from hydrophilic matrix system is mainly controlled by the diffusion through the swollen gel layer, whereas release of poorly soluble drug is dominantly controlled by the polymer erosion (relaxation) [10] . Tablet geometry has also profound influence on the drug release from diffusion-controlled systems and this has been studied in details by Siepmann et al. [11] . Thus, the effect of a tablet surface/tablet volume ratio (SA/Vol) on the drug release from hydrophilic matrices was investigated for hypromellose matrix tablets [12] and for hydroxypropylcellulose matrix tablets [13] .
In formulation of hydrophilic matrix tablets with high-dose, highly soluble drug, the two important issues, regarding selecting of proper matrix polymer, should be considered: the capability of polymer to prevent premature drug release, as well as ability to sustain drug release with predictable kinetics. Another important characteristic of matrix tablets should be acceptable mechanical properties in order to maintain tablet integrity during further processing, such as packaging and coating and application by the patient. Mechanical properties of powder mixtures and compacts can be assessed through evaluation of compressibility (solid fraction vs. compaction pressure), compactibility (tensile strength vs. solid fraction) and tabletability (tensile strength vs. compaction pressure). Yang et al. have proved that under applied compression pressure the consolidation mechanism of PEO follows plastic deformation. However, characteristic viscoelastic behavior of PEOs with large axial expansion after compression results in production of low tensile strength tablets. According to these results it was suggested that PEO polymers should be used with highly compactible excipients [14] . Comparison of the drug release, as well as mechanical characteristics between hypromellose 100000 mPa s and different high viscosity PEOs (Polyox WSR 1105, 301 and 303), was performed on matrix tablets containing metformin HCl as a model drug. The results of this study proved lower tabletability of PEO in respect to HPMC [15] . Most of the studies that investigate mechanical characteristics of hydrophilic matrix tablets were conducted on either excenter tablet press or instrumented small rotary press. There are numerous advantages of using compaction simulator in comparison to conventional tablet presses. It offers studying of basic compaction mechanisms, evaluation of influence of process variables on tablet properties, determination of scale-up parameters, creating compaction data bank, and fingerprinting of new active pharmaceutical ingredients (APIs) or excipients [16] . Using of compaction simulator enables evaluation and comparison of powder mechanical properties in simulated production conditions. Mathematical equations can be used to describe compaction events and density-pressure relationships that predict the pressures required for achieving an optimum compact density. This understanding has found active application in solving the analytical problems related to tableting, such as capping, lamination, picking, sticking, etc. Mathematical models, such as forcetime, force-distance, and die-wall force parameters are used to describe work of compaction, elasticity, plasticity, and time dependent deformation behavior of pharmaceuticals. Parameters such as the bonding index, brittle fracture index and strain index can be used to predict compaction related problems [16] .
This study investigates using of high molecular weight PEO (Polyox WSR coagulant) for the preparation of sustained release matrix tablets with high dose, highly soluble model drug, tramadol HCl. Both drug release and tablets mechanical properties were recognized as critical quality attributes of hydrophilic matrix tablets. Critical formulation (proportion of PEO polymer, type of insoluble filler, proportion of tramadol HCl, amount of drug in tablet and tablet diameter) and process parameters (compression pressure) were selected in the study and the influence of these parameters on drug release and tablet mechanical properties was evaluated. Aim of this study was preliminary evaluation of selected variables on tablet quality attributes, since all variables were varied on two levels through screening experimental design.
EXPERIMENTAL Materials
The following materials were used: polyethylene oxide (Polyox WSR coagulant, Dow Chemical Company, Midland, TX, USA), microcrystalline cellulose (Avicel PH 102, FMC Biopolymer, USA), partially pregelatinized maize starch (Starch 1500, Colorcon, Dartford, Kent, UK), colloidal silicon dioxide (Aerosil 200 Pharma, Degussa), magnesium stearate (Mallinckrodt, St. Louis, MO, USA). Tramadol HCl (Hemofarm A.D., Vršac, Serbia) was used as model of high dose, highly water soluble drug.
Experimental design
In the first part, the experiments were conducted to evaluate the influence of formulation (proportion of PEO polymer, type of insoluble filler, proportion of tramadol HCl, amount of drug in tablet and tablet diameter) and process parameter (compression pressure) on tramadol release. Percentage of drug release from matrix tablets after 30 and 240 min were selected as response variables. Experiments were performed according to 2 5-2 fractional factorial design, as presented in the Table 1 .
In order to eliminate influence of matrix tablets geometry on drug release, normalization of the percentage of drug released after 30 and 240 min, was performed by dividing obtained drug released percentage with surface area per volume ratio (SA/Vol) of tablets.
In the second part of the study 2 3 full factorial design was used to evaluate the influence of the matrix polymer proportion, type of filler and drug proportion on the tablet mechanical properties. Levels of investigated variables are presented in Table 1 . Tensile strength (σ t ) was used as an indicator of tablets mechanical properties, enabling comparison of mechanical properties of tablets with different dimensions. Tensile strength was calculated according to the following equation:
where F is the crushing force, d is the tablet diameter and h is the tablet thickness.
Tablets preparation
Powder mixtures for compression were prepared by using Turbula® shaker-mixer (Glen Mills Inc., Clifton, NJ, USA). Tablets were compressed with direct compression method by using of Presster TM single station compacting simulator (Metropolitan Computing Corporation, East Hanover, NJ, USA). Simulation of the rotary tablet press Korsch PH336 was used, with simulated die table speed of 30 rpm which conforms to 65000 tablets per hour and dwell time of 20 ms. Tablets were prepared using punches with diameters of 7, 10 and 13 mm, while tablet masses were 180, 360 and 720 mg, respectively, according to the experimental design. Compression pressure was calculated from the measured compaction force per cross-sectional area of tablets. Tablets were compressed on different compaction pressures in the range of 100-500 MPa with simulation of the compaction profile of the Korch PH336 rotary tablet press. Tensile strength was calculated from measured hardness and tablet dimensions. Influence of the selected input variables on the tablet tensile strength was analyzed.
Drug release testing
Drug release test was performed using rotating basket apparatus (Erweka, Hausemmann, Germany) during 4 h (rotational speed 75 rpm, medium volume 600 ml). Samples were taken after predefined time intervals: 30, 120, 180, 240, 360 and 480 min and the amount of dissolved tramadol HCl was determined spectrophotometrically at λ = 271 nm. The data collected up to 240 min were selected for modeling of drug release. During the drug release testing, pH value of the medium was changed by adding buffer solutions as follows: in the first 30 min, pH 1.2; from 30-120 min, pH 2.3; from 120-180 min, pH 6.8; from 180-240 min, pH 7.2. Artificial gastric juice pH 1.2 was used as well as two buffer solutions for changing pH value during dissolution test:
Buffer 1: K 2 HPO 4 , 63 g/ 100 ml (6 ml at 31 min). Buffer 2: NaOH 15 g/ 100 ml (6 ml at 121 min and 3 ml at 181 min).
Mechanical characterization of tablets
Tablet hardness was measured using the 8M tablet hardness tester (Dr. Schleuniger Pharmatron, Thun, Switzerland) and tablet dimensions were measured with digital caliper. Tensile strength was calculated from dimensions of tablets and measured hardness, according to the Eq. (1).
RESULTS AND DISCUSSION

Evaluation of drug release from PEO matrices
Tramadol HCl release profiles from PEO matrices (formulations F1-F8) are presented in Figure 1 .
Based on assumption that in hydrophilic matrices with high viscosity polymers and high water-soluble drug diffusion release mechanism is dominating in respect to erosion, drug release process follows Higuchi's model. There is linear relationship between drug release and square-root-of-time (Figure 2 ) in the certain time intervals and it is related to geometrical characteristics of matrix tablets. Calculated determination coefficient values (R 2 ) for all formulations were above 0.96, indicating good fitting to Higuchi model.
Percentages of tramadol HCl released after 30 and 240 min were selected as indicator of polymer ability to prevent premature drug release and enable sustained release of drug. Furthermore, both time points are within the interval in which drug release follows Higuchi's model. Normalized values of drug released percentage were used in order to eliminate influence of geometrical characteristics on drug release rate. Normalization was performed by dividing percentage of drug released with surface area per volume ratio (SA/Vol) of matrix tablets ( Table 2 ). The influence of selected formulation and process parameters (proportion of PEO polymer, type of insoluble filler, proportion of tramadol HCl, amount of drug in tablet, tablet diameter and compression pressure) on normalized percentage of drug released at 30 and 240 min was analyzed and presented on Figure 3 . Proportion of drug in tablet exhibits statistically significant effect on drug release after 30 min (p < 0.05). With Inc- reasing proportion of drug in tablet, drug release increased.
Influence of other formulation and process variables in selected range have no statistical significant influence on tramadol HCl release rate. For the drug release at later time point, 240 min, proportion of tramadol HCl in the formulation has statistical significant influence on drug release, too.
Mechanical characterization of matrices with polyethylene oxide
Full factorial design was performed in order to evaluate influence of input variables (proportion of polymer, type of filler and proportion of tramadol HCl per tablet) on mechanical characteristics of matrix tablets. Due to different dimensions of tablets the tensile strength was used for evaluation of mechanical characteristics of matrix tablets.
Profiles of tensile strength versus compaction pressure are presented in the Figure 4 .
Compression of tablet mixture was performed with compression force up to 40 kN, since the punch face diameter of 13 mm and compression pressure of about 300 MPa compression force is near to maximum possible compression force which could be performed on compaction simulator. Tensile strengths of matrix tab- lets on compaction pressures of 120 and 250 MPa were analyzed and compared as output variables (Table 3) .
Those values of tensile strength were extracted from trend lines of tabletability profiles (Figure 4) . Value for compaction pressure of 120 MPa corresponds to values of tensile strength in ascending part of the tabletability profiles diagrams in all trials, while compression pressure of 250 MPa is in the part where the profile reaches plateau. The higher values of tensile strength were obtained when Avicel PH 102 was used as filler comparing to the Starch 1500. Increase of tramadol HCl in tablet mixture negatively influences on tensile strength, while increase of PEO polymer in tablet mixture has positive impact on tensile strength.
Pareto diagram of the influence of input variables on tensile strength (for compression pressure of approximately 120 and 250 MPa respectively) is presented in Figure 5 .
For PEO matrix tablets almost all input variables exhibit statistically significant effect on tablet tensile strength, with the largest influence of filler type. Mechanical properties of the matrix tablets with highly compressible MCC as filler are significantly better comparing to Starch 1500.
Influence of proportions of polymer, filler and drug (comprising 100% of tablet) on tensile strength is presented in Figure 6a and b for Avicel PH 102 and Starch 1500, respectively. 
CONCLUSION
In this study, the influence of critical formulation and process parameters on tramadol HCl release from PEO matrix tablets and tablet mechanical properties was evaluated using screening experimental design. Proportion of drug in tablet exhibits statistically significant effect on drug release in the evaluated range. By increasing the proportion of drug in tablet, the drug release will be increased. Other formulation and process variables in selected ranges have no statistical influence on tramadol HCl released rate.
Regarding mechanical properties of tablets, type of filler has the most critical effect on the powder mixture tabletability. Mechanical properties of matrix tablets are significantly better with microcrystalline cellulose compared to partially pregelatinized starch. The highest tensile strength was obtained with Avicel PH 102 as filler and with higher percentage of polymer. Obtained results present preliminary evaluation of investigated variables on tablet quality attributes. Since all results were obtained from experiments where variables were varied on two levels, additional experimental work is needed in the future in order to establish mathematical model which will define influence of investigated variables on drug release and tablet mechanical properties.
These findings could be useful in optimization of PEO sustained release matrix tablets with tramadol HCl, as high dose, highly soluble model drug.
